Enlightenment Research, LLC Ocugen, Inc. Transaction History

Enlightenment Research, LLC

  • $0
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.36 - $8.51 $94,764 - $126,799
-14,900 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$5.52 - $15.68 $2,760 - $7,840
500 Added 3.47%
14,900 $120,000
Q1 2021

May 12, 2021
BUY
$1.66 - $15.81 $23,904 - $227,664
14,400 New
14,400 $98,000

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $156M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Enlightenment Research, LLC Portfolio

Follow Enlightenment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enlightenment Research, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email